-
Jan 24, 2025 | 
knowridge.com | Mona Bafadhel |Richard Russell
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone. Unfortunately, these drugs don’t work for everyone and they have significant levels of serious side-effects.
-
Jan 9, 2025 | 
kcl.ac.uk | Mona Bafadhel |Lucy C Chappell
Two King’s academics, Professor Mona Bafadhel and Professor Lorna Fraser, have been awarded the prestigious National Institute for Health and Care Research (NIHR) Research Professorships. The NIHR Research Professorships scheme funds and supports research leaders of the future. Each will receive a five-year award of up to £2 million. This includes three support posts, research costs and access to a leadership and development programme..
-
Dec 6, 2024 | 
thenewdaily.com.au | Mona Bafadhel
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone. Unfortunately, these drugs don’t work for everyone and they have significant levels of serious side-effects.
-
Nov 29, 2024 | 
msn.com | Mona Bafadhel |Richard Russell |Sanjay Ramakrishnan
Continue reading More for You
-
Nov 29, 2024 | 
theconversation.com | Mona Bafadhel |Richard Russell |Sanjay Ramakrishnan
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone. Unfortunately, these drugs don’t work for everyone and they have significant levels of serious side-effects.
-
Nov 28, 2024 | 
kcl.ac.uk | Mona Bafadhel |Richard Russell
The findings, published today in The Lancet Respiratory Medicine, could be “game-changing” for millions of people with asthma and COPD around the world, scientists say. Asthma attacks and COPD flare-ups (also called exacerbations) can be deadly. Every day in the UK four people with asthma and 85 people with COPD will tragically die. Both conditions are also very common, in the UK someone has an asthma attack every 10 seconds. Asthma and COPD costs the NHS £5.9B a year.
-
May 30, 2024 | 
erj.ersjournals.com | Mario Cazzola |Mona Bafadhel |Paola Rogliani
Conflict of interest: M.
-
Apr 18, 2024 | 
kcl.ac.uk | Mona Bafadhel |Richard Russell
The collaborative research, led from the University of Oxford, has developed a new tool that more accurately predicts risk of cardiovascular diseasesCollaborative research, led from the University of Oxford and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.
-
Dec 19, 2023 | 00859-x/abstract&sz=64)
ejog.org | Jana Hutter |Alena Uus |Carla L. Avena-Zampieri |Maria Deprez |Kelly Payette |Megan Hall | +7 more
Highlights•An MRI based approach and application of deformable slice-to-volume reconstruction is feasible for characterisation of preterm lung development. •Mean T2* values were lower in the preterm cohort than in controls. •Alterations in pulmonary development associated with preterm birth may commence in the antenatal period.
-
Nov 15, 2023 | 
kcl.ac.uk | Mona Bafadhel
A healthcare research consortium including King’s Centre for Lung Health, has been awarded four million euros (£3.8 million) funding by the European Innovation Council to accelerate the development of diagnostics technology for patients living with chronic obstructive pulmonary disease (COPD). COPD is a lung disease that affects nearly 400 million people around the world and ranks as the third leading cause of death worldwide.
